Status:
COMPLETED
Asthma and Quantifying Delivery Of Radio Labeled Aerosol
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Asthma
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Introduction: Inhalation therapy has been established as an efficient route to treat asthma exacerbations, but coupled to noninvasive ventilation (NIV) remains quite challenging. Objectives: The aim ...
Eligibility Criteria
Inclusion
- stable moderate to severe asthma (FEV1 \> 60% and \> 80% and PEF with a variation of 30% from the predicted values to moderate and FVE1 \> 60% and );
- More than one year elapsed since the diagnosis of asthma;
- None exacerbation in the last six months;
- Age between 18 - 60 years, from both sexes,
- Able to understand verbal commands
- Consent to participate in this protocol.
Exclusion
- presence of dyspnea;
- smoking history;
- cardiopulmonary diseases (chronic obstructive pulmonary disease, pneumonia, cardiac failure, myocardial infarction, pneumothorax);
- hyperthermia;
- hemodynamic instability (heart rate \> 150 bpm and systolic blood pressure \< 90 mmHg);
- arrhythmia absence;
- pregnancy
- contraindications for use of noninvasive ventilation
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01823926
Start Date
October 1 2011
End Date
August 1 2012
Last Update
April 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas de Pernambuco
Recife, Pernambuco, Brazil, 50670-901